This text is a result of machine translation.
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
The Central Committee decided that wangyonghong would be appointed secretary of the leading Party group and director general of the state organ affairs administration
Beijing Pilots The DRG External Payment Mode
DRG refers to the diagnosis-related group used to classify the patient and set up a system to ensure the care provided is necessary. The National Healthcare Security Administration will pay the hospital a predetermined amount according to a patient’s DRG.
Jul 16, 2022 12:12 AM
China Mobile Returns to A-share Market Planning to Issue 965 Mn Shares
The announcement shows that the funds raised by the telecommunication company will be used for projects such as 5G boutique network construction, new Cloud infrastructure construction, gigabit smart home construction, new-generation information technology research and development, digital intelligence ecology construction, and so on.
May 18, 2021 11:28 AM
Zhao Dachun, deputy general manager of China Mobile: ensure that more than one million 5g base stations are opened before the 20th CPC National Congress
Din Tai Fung and the Globalization of Chinese Cuisine
Dec 03, 2024 08:26 PM
Podcast Marketing, A Useful Tool for Companies Going Overseas
Dec 02, 2024 02:15 PM
Black Friday and Cyber Monday: How to Win the Cross-Border E-Commerce Traffic Battle
Nov 26, 2024 06:18 PM